| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.53 | 0.07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.28 | 6e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.27 | 2e-12 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |